Atricure Inc. buy UBS Group AG
Start price
30.10.24
/
50%
€29.29
Target price
30.10.25
€36.85
Performance (%)
3.79%
End price
31.10.25
€30.40
Summary
This prediction ended on 31.10.25 with a price of €30.40. With a performance of 3.79%, the BUY prediction by UBS_Group_AG for Atricure Inc. closed with a slight gain. UBS_Group_AG has a follow-up prediction for Atricure Inc. where he still thinks Atricure Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -1.149% | -1.149% | -44.516% |
| iShares Core DAX® | 0.299% | 4.394% | 21.011% |
| iShares Nasdaq 100 | 0.666% | 1.175% | 6.494% |
| iShares Nikkei 225® | -0.656% | -0.055% | 13.439% |
| iShares S&P 500 | 0.352% | 1.378% | 4.171% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten